Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6641800 | ASTRAZENECA | Pressurized aerosol compositions comprising powdered medicament dispersed in hydrofluoroalkane |
Sep, 2012
(11 years ago) | |
US5972919 | ASTRAZENECA | Combination of a bronchodilator and a steroidal anti-inflammatory drug for the treatment of respiratory disorders, as well as its use and the preparation thereof |
Dec, 2012
(11 years ago) | |
US5674860 | ASTRAZENECA | Combination of a bronchodilator and a steroidal anti-inflammatory drug for the treatment of respiratory disorders |
Oct, 2014
(9 years ago) | |
US6123924 | ASTRAZENECA | Pressurized aerosol inhalation compositions |
Sep, 2017
(6 years ago) | |
US6123924 (Pediatric) | ASTRAZENECA | Pressurized aerosol inhalation compositions |
Mar, 2018
(6 years ago) | |
US8461211 | ASTRAZENECA | Use for budesonide and formoterol |
Sep, 2018
(5 years ago) | |
US7897646 | ASTRAZENECA | Use for budesonide and formoterol |
Sep, 2018
(5 years ago) | |
US7367333 | ASTRAZENECA | Inhalation device |
Nov, 2018
(5 years ago) | |
US8461211 (Pediatric) | ASTRAZENECA | Use for budesonide and formoterol |
Mar, 2019
(5 years ago) | |
US7897646 (Pediatric) | ASTRAZENECA | Use for budesonide and formoterol |
Mar, 2019
(5 years ago) | |
US7367333 (Pediatric) | ASTRAZENECA | Inhalation device |
May, 2019
(4 years ago) | |
US7967011 | ASTRAZENECA | Inhalation device |
Aug, 2021
(2 years ago) | |
US7967011 (Pediatric) | ASTRAZENECA | Inhalation device |
Feb, 2022
(2 years ago) | |
US11311558 | ASTRAZENECA | Composition for inhalation |
Jan, 2023
(1 year, 2 months ago) | |
US10166247 | ASTRAZENECA | Composition for inhalation |
Jan, 2023
(1 year, 2 months ago) | |
US8575137 | ASTRAZENECA | Composition for inhalation |
Jan, 2023
(1 year, 2 months ago) | |
US7759328 | ASTRAZENECA | Composition for inhalation |
Jan, 2023
(1 year, 2 months ago) | |
US8143239 | ASTRAZENECA | Composition for inhalation |
Jan, 2023
(1 year, 2 months ago) | |
US7759328 (Pediatric) | ASTRAZENECA | Composition for inhalation |
Jul, 2023
(8 months ago) | |
US8575137 (Pediatric) | ASTRAZENECA | Composition for inhalation |
Jul, 2023
(8 months ago) | |
US8143239 (Pediatric) | ASTRAZENECA | Composition for inhalation |
Jul, 2023
(8 months ago) | |
US11311558 (Pediatric) | ASTRAZENECA | Composition for inhalation |
Jul, 2023
(8 months ago) | |
US10166247 (Pediatric) | ASTRAZENECA | Composition for inhalation |
Jul, 2023
(8 months ago) | |
US8875699 | ASTRAZENECA | Inhaler cap strap |
Nov, 2024
(6 months from now) | |
US8875699 (Pediatric) | ASTRAZENECA | Inhaler cap strap |
May, 2025
(1 year, 13 days from now) | |
US7587988 | ASTRAZENECA | Inhaler device counter |
Apr, 2026
(1 year, 11 months from now) | |
US7587988 (Pediatric) | ASTRAZENECA | Inhaler device counter |
Oct, 2026
(2 years from now) | |
US8387615 | ASTRAZENECA | Inhaler cap strap |
Mar, 2027
(2 years from now) | |
US8387615 (Pediatric) | ASTRAZENECA | Inhaler cap strap |
Sep, 2027
(3 years from now) | |
US8528545 | ASTRAZENECA | Inhaler device that reduces the risk for miscounting a dosage |
Oct, 2028
(4 years from now) | |
US8616196 | ASTRAZENECA | Inhalation device and a method for assembling said inhalation device |
Apr, 2029
(4 years from now) | |
US8528545 (Pediatric) | ASTRAZENECA | Inhaler device that reduces the risk for miscounting a dosage |
Apr, 2029
(4 years from now) | |
US8616196 (Pediatric) | ASTRAZENECA | Inhalation device and a method for assembling said inhalation device |
Oct, 2029
(5 years from now) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Indication(I-582) | Feb 27, 2012 |
M(M-210) | Sep 11, 2020 |
New Patient Population(NPP) | Jan 27, 2020 |
M(M-214) | Dec 20, 2020 |
Pediatric Exclusivity(PED) | Jul 27, 2020 |
Market Authorisation Date: 21 July, 2006
Treatment: Use for the treatment of asthma; Use for the treatment of chronic obstructive pulmonary disease (copd), including chronic bronchitis and emphysema; Use for maintenance treatment of chronic obstructive...
Dosage: AEROSOL, METERED;INHALATION